Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Endeavor Biomedicines
Biotech
Endeavor links IPF drug to improved lung function in phase 2
The Hedgehog inhibitor data sent a sonic pulse through a sector currently dominated by drugs that only slow the decline of the disease.
Nick Paul Taylor
May 20, 2024 5:55am
Fibrosis-focused Endeavor bags $132.5M series C
Apr 24, 2024 7:30am
Longtime BioMarin CEO hands off baton—Chutes & Ladders
Nov 3, 2023 9:30am
Endeavor signs $430M deal for Hummingbird's HER3-targeted ADC
Oct 19, 2023 10:29am
AbbVie ditches Morphic's fibrosis program after 'safety signal'
Feb 24, 2022 3:25pm
Endeavor nabs $101M for IPF, cancer trials—and asset shopping
Feb 7, 2022 8:00am
